MAHADEVIA ANKIT (See Remarks) sold 9.1% of their position (69.22K shares) of SPERO THERAPEUTICS, INC. on the open market
Open‑market sale worth $54.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/5/2025ACC: 0000950170-25-014849
DirectorOfficer· See Remarks
Since Jul 2018
-69.22K
Net shares
Net seller
$54.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
69.22K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−13.96K
Price / share
$0.78
Trade value
$10.89K
% of position
1.8%
2/5/2025
759.09K→745.13K
Common Stock
Direct
Shares
−55.26K
Price / share
$0.78
Trade value
$43.10K
% of position
7.4%
2/5/2025
745.13K→689.87K
Total
Net shares
−69.22K
Net value
-$53.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/5/2025 | S · Sale | −13.96K | $0.78 | $10.89K | 1.8% | 759.09K | 745.13K |
| Common Stock Direct | 2/5/2025 | S · Sale | −55.26K | $0.78 | $43.10K | 7.4% | 745.13K | 689.87K |
| Total | −69.22K | -$53.99K | ||||||
Derivative Transactions0
No derivative transactions reported